Abstract
Alveolar soft part sarcoma (ASPS) is a rare disease of the soft tissue. Although the disease is rare, it is refractory to chemotherapy and radiation. En bloc surgical resection offers the best chance of cure. In this article we report the case of a 28-year-old woman who presented with buttock and leg pain, bowel, bladder and gait impairment and a large mass in the sacrum. Following surgical excision, the lesion was proven to be ASPS. On pathology, the mass was TFE3 (transcription factor E3) positive, indicating the presence of the ASPL-TFE3 (novel gene-transcription factor) translocation. Following surgery, the patient had improvement in her pain and ambulation; however, she refused adjuvant therapy to pursue hospice care and succumbed to her disease 2 years after surgery. On a review of the literature, it was found that ASPS of the bone constitutes a rare and formidable subset of this disease. Further, metastases related to ASPS are common in the lungs, liver, brain, and lymph nodes. The degree of dissemination is a predictor of outcome, with 5-year survival of 81–88 % in patients with local disease and only 20–46 % in patients with metastatic disease at the time of presentation. Brain metastases at the time of presentation portend the worst prognosis.
References
Christopherson WM, Foote Jr FW, Stewart FW. Alveolar soft-part sarcomas; structurally characteristic tumors of uncertain histogenesis. Cancer. 1952;5:100–11.
Auerbach HE, Brooks JJ. Alveolar soft part sarcoma. A clinicopathologic and immunohistochemical study. Cancer. 1987;60:66–73.
Lieberman PH, Foote Jr FW, Stewart FW, et al. Alveolar soft-part sarcoma. JAMA. 1966;198:1047–51.
Folpe AL, Deyrup AT. Alveolar soft-part sarcoma: a review and update. J Clin Pathol. 2006;59:1127–32.
Pennacchioli E, Fiore M, Collini P, et al. Alveolar soft part sarcoma: clinical presentation, treatment, and outcome in a series of 33 patients at a single institution. Ann Surg Oncol. 2010;17:3229–33.
Portera Jr CA, Ho V, Patel SR, et al. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer. 2001;91:585–91.
Evans HL. Alveolar soft-part sarcoma. A study of 13 typical examples and one with a histologically atypical component. Cancer. 1985;55:912–7.
Khanna P, Paidas CN, Gilbert-Barness E. Alveolar soft part sarcoma: clinical, histopathological, molecular, and ultrastructural aspects. Fetal Pediatr Pathol. 2008;27:31–40.
Koguchi Y, Yamaguchi T, Yamato M, et al. Alveolar soft part sarcoma of bone. J Orthop Sci. 2005;10:652–5.
Lieberman PH, Brennan MF, Kimmel M, et al. Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer. 1989;63:1–13.
Ogose A, Yazawa Y, Ueda T, et al. Alveolar soft part sarcoma in Japan: multi-institutional study of 57 patients from the Japanese Musculoskeletal Oncology Group. Oncology. 2003;65:7–13.
Casanova M, Ferrari A, Bisogno G, et al. Alveolar soft part sarcoma in children and adolescents: a report from the Soft-Tissue Sarcoma Italian Cooperative Group. Ann Oncol. 2000;11:1445–9.
Kayton ML, Meyers P, Wexler LH, et al. Clinical presentation, treatment, and outcome of alveolar soft part sarcoma in children, adolescents, and young adults. J Pediatr Surg. 2006;41:187–93.
Pappo AS, Parham DM, Cain A, et al. Alveolar soft part sarcoma in children and adolescents: clinical features and outcome of 11 patients. Med Pediatr Oncol. 1996;26:81–4.
Daigeler A, Kuhnen C, Hauser J, et al. Alveolar soft part sarcoma: clinicopathological findings in a series of 11 cases. World J Surg Oncol. 2008;6:71.
Lillehei KO, Kleinschmidt-DeMasters B, Mitchell DH, et al. Alveolar soft part sarcoma: an unusually long interval between presentation and brain metastasis. Hum Pathol. 1993;24:1030–4.
Stacchiotti S, Negri T, Zaffaroni N, et al. Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect. Ann Oncol. 2011;22:1682–90.
Anderson ME, Hornicek FJ, Gebhardt MC, et al. Alveolar soft part sarcoma: a rare and enigmatic entity. Clin Orthop Relat Res. 2005;438:144–8.
Kodama K, Doi O, Higashiyama M, et al. Surgery for multiple lung metastases from alveolar soft-part sarcoma. Surg Today. 1997;27:806–11.
Park YK, Unni KK, Kim YW, et al. Primary alveolar soft part sarcoma of bone. Histopathology. 1999;35:411–7.
Reichardt P, Lindner T, Pink D, et al. Chemotherapy in alveolar soft part sarcomas. What do we know? Eur J Cancer. 2003;39:1511–6.
Sherman N, Vavilala M, Pollock R, et al. Radiation therapy for alveolar soft-part sarcoma. Med Pediatr Oncol. 1994;22:380–3.
Furey JG, Barrett DL, Seibert RH. Alveolar soft-part sarcoma. Report of a case presenting as a sacral bone tumor. J Bone Joint Surg Am. 1969;51:185–90.
Dutt AK, Balasegaram M, Bin Din O. Alveolar soft-part sarcoma with invasion of bone. A case report. J Bone Joint Surg Am. 1969;51:765–8.
Zhu FP, Lu GM, Zhang LJ, et al. Primary alveolar soft part sarcoma of vertebra: a case report and literature review. Skeletal Radiol. 2009;38:825–9.
Stacchiotti S, Tamborini E, Marrari A, et al. Response to sunitinib malate in advanced alveolar soft part sarcoma. Clin Cancer Res. 2009;15:1096–104.
Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159:179–92.
Ladanyi M, Lui MY, Antonescu CR, et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene. 2001;20:48–57.
Argani P, Aulmann S, Illei PB, et al. A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol. 2010;34:1395–406.
Argani P, Lui MY, Couturier J, et al. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene. 2003;22:5374–8.
Vistica DT, Hollingshead M, Borgel SD, et al. Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy. J Pediatr Hematol Oncol. 2009;31:561–70.
Acknowledgements
This work was supported with funding from the AOSpine Foundation for the Knowledge Forum Primary Tumor Retrospective Study.
Conflict of interest
The authors declare that they have no conflict of interest.
The authors report no competing financial interests related to this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zadnik, P.L., Yurter, A., DeLeon, R. et al. Alveolar soft-part sarcoma in the sacrum: a case report and review of the literature. Skeletal Radiol 43, 115–120 (2014). https://doi.org/10.1007/s00256-013-1737-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-013-1737-x